As a pioneer in the sequencing field, GATC Biotech is Europe’s leading service provider of sequencing and bioinformatics. For over 27 years the company has developed innovative sample-to-answer solutions for DNA and RNA sequencing with bioinformatics analysis for industry, research, and health care.
The highly integrated and fully automated processes for Sanger as well as for next-generation sequencing and diagnostic solutions deliver reliable, ready-to-use results backed by ISO 17025 accreditation and ISO 13485 certification. Currently, one of the company’s entrepreneurial focuses is on a completely new approach in the field of personalised medicine. GATCLIQUID is the world’s first service for cancer research and diagnosis based on liquid biopsy.
GATC Biotech offers unmatched flexibility to customers interested in any kind of genomics, such as transcriptome, epigenome, exome or whole genome analysis. The company is involved in numerous successful collaborations with world-renowned universities, academic institutions, pharmaceutical and biotechnological companies. Moreover, GATC Biotech has a proven record of publicly funded projects by the EU and other national agencies.